Unveiling Vertex (VRTX) Q1 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts expect Vertex Pharmaceuticals (VRTX) to post quarterly earnings of $4.10 per share in its upcoming report, which indicates a year-over-year increase of 34.4$2.56 billion, up 7.8% from the year-ago quarter.The current level reflects an upward revision of 0.4% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Befor ...